STONE HEISZ LESLIE 4

What Happened Leslie Stone Heisz, a director of Edwards Lifesciences Corporation (EW), received a grant of 3,251 restricted stock units (RSUs) on May 8, 2026. The grant price is $0 (standard for awards); reported value at grant is $0 on the Form 4. This is an award/grant (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-08 (reported same day)
• Transaction type/code: Award/Grant (A)
• Shares/units granted: 3,251 RSUs
• Price: $0.00 per RSU (standard grant)
• Shares owned after transaction: Not disclosed on this Form 4 (the filing only reflects the change)
• Vesting/footnote: RSUs granted under the 2020 Nonemployee Directors Stock Incentive Program; scheduled to become 100% vested on the earlier of one year from grant or the issuer’s next annual meeting of stockholders
• Timeliness: Filed on the same date as the grant (no late filing indicated)

Context RSUs are a form of equity compensation that convert into company shares when they vest; they do not require an outlay of cash by the recipient at grant. Grants to non-employee directors are common and part of routine board compensation. This Form 4 reports the change in beneficial ownership only and does not indicate other holdings the reporting person may have.